Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:45 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC0
0%
-2,583,821decrease
(Position Closed)
View
2023-02-14
4:45 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
RA CAPITAL MANAGEMENT L.P.0
0%
-2,246,503decrease
(Position Closed)
View
2023-02-14
4:07 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
Venrock Healthcare Capital Partners III L.P.2,208,812
6.4%
136,803increase
(+6.60%)
View
2023-02-14
1:13 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Boxer Capital LLC698,861
2%
-1,540,000decrease
(-68.78%)
View
2023-02-14
11:03 am
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Ikarian Capital LLC460,416
1.3%
-1,289,627decrease
(-73.69%)
View
2023-02-13
09:06 am
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
BlackRock Inc.
BLK
1,727,829
5%
1,727,829increase
(New Position)
View
2023-01-19
09:19 am
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
GOLDMAN SACHS GROUP INC
GS
2,750,385
8%
2,750,385increase
(New Position)
View
2023-01-18
4:40 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
INTEGRATED CORE STRATEGIES (US) LLC2,195,029
6.4%
290,732increase
(+15.27%)
View
2022-10-31
4:40 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
INTEGRATED CORE STRATEGIES (US) LLC1,904,297
6.3%
1,904,297increase
(New Position)
View
2022-10-24
12:46 pm
Sale
13DMilestone Pharmaceuticals Inc.
MIST
Novo Holdings A/S1,378,538
4.6%
-719,175decrease
(-34.28%)
View
2022-09-26
4:04 pm
Purchase
13DMilestone Pharmaceuticals Inc.
MIST
Novo Holdings A/S2,097,713
7%
16,828increase
(+0.81%)
View
2022-09-19
9:14 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
Venrock Healthcare Capital Partners III L.P.2,072,009
6.9%
2,072,009increase
(New Position)
View
2022-02-14
4:54 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Boxer Capital LLC2,238,861
7.5%
-238,333decrease
(-9.62%)
View
2022-02-14
4:36 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
Ikarian Capital LLC1,750,043
5.9%
-86,502decrease
(-4.71%)
View
2022-02-14
4:11 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
RA CAPITAL MANAGEMENT L.P.2,246,503
7.5%
-81,211decrease
(-3.49%)
View
2022-02-14
08:03 am
Sale
13GMilestone Pharmaceuticals Inc.
MIST
RTW INVESTMENTS LP4,315,102
14.4%
-99decrease
(-0.00%)
View
2022-02-11
4:32 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
ORBIMED CAPITAL LLC2,583,821
8.7%
90,712increase
(+3.64%)
View
2021-02-16
4:57 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
Boxer Capital LLC2,477,194
8.3%
700,000increase
(+39.39%)
View
2021-02-16
4:39 pm
Purchase
13GMilestone Pharmaceuticals Inc.
MIST
RA CAPITAL MANAGEMENT L.P.2,327,714
7.8%
2,327,714increase
(New Position)
View
2021-02-16
12:24 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
PRICE T ROWE ASSOCIATES INC374,957
1.2%
-911,550decrease
(-70.85%)
View
Goto 0, 1, Next